Lithocholic Acid’s Ionic Compounds as Promising Antitumor Agents: Synthesis and Evaluation of the Production of Reactive Oxygen Species (ROS) in Mitochondria
2024

Lithocholic Acid's Ionic Compounds as Antitumor Agents

Sample size: 4 publication 10 minutes Evidence: moderate

Author Information

Author(s): Chobanov Nuri M., Dzhemileva Lilya U., Dzhemilev Usein M., D’yakonov Vladimir A.

Primary Institution: N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences

Hypothesis

Can new ionic compounds derived from lithocholic acid exhibit antitumor activity through their effects on mitochondrial processes?

Conclusion

The synthesized ionic compounds demonstrate promising antitumor activity by affecting mitochondrial oxidation and phosphorylation processes.

Supporting Evidence

  • Compounds 5a and 5b showed the highest production of ROS ions.
  • Compound 5a was identified as the most toxic for all cell lines.
  • All synthesized compounds exhibited cytochrome c release from mitochondria.
  • The study demonstrated that lithocholic acid derivatives can induce apoptosis.
  • Compounds based on lithocholic acid showed enhanced permeability and solubility.

Takeaway

Scientists created new compounds from a natural substance called lithocholic acid to see if they could help fight cancer by affecting tiny parts of cells called mitochondria.

Methodology

The study involved synthesizing new ionic compounds from lithocholic acid and testing their effects on various human cancer cell lines using flow cytometry techniques.

Limitations

The study primarily focused on in vitro experiments, which may not fully represent in vivo conditions.

Participant Demographics

Human cancer cell lines Jurkat, K562, A549, and HEK293 were used.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/antiox13121448

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication